THERAVANCE BIOPHARMA INC
TBPHNASDAQ🏆 #2559 by market capEarnings Nov 9US Equity
$17.04▼ $0.01 (−0.03%)
Market closed · at closeTrack TBPH
Get earnings, price moves & breaking news on Telegram
24h▼ 0.0%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$883M
Small Cap
📈Revenue Growth (YoY)
+35.1%
High Growth
📊Gross Margin
100.0%
High
💵FCF Margin
269.7%
Strong
⚖️P/S Ratio
8.5x
Elevated
Otter Score
64
Fair
Earnings
Q3 · 2026Reported 2026-08-10Earnings Per Share
Actual
-0.11
Expected
0.07
miss
−251.70%
YoY −110.20%
Revenue
Actual
$20.73M
Expected
$22.49M
miss
−7.80%
YoY −20.90%
Consensus estimates
Recent quarters
Q3 2026
-0.11
miss
Q2 2026
-0.10
miss
Q1 2026
0.06
miss
Q4 2025
0.04
beat